Preparation and properties of new co-crystals of ibandronate with gluco- or galactopyranoside derivatives

Molecules

Volumn 15, Issue 12, 2010, Pages 8973-8987

  Oktabec, Zbynek ^a,b   Kos, Jiri ^c   Mandelova, Zuzana ^a,c   Havelkova, Lenka ^c   Pekarek, Tomas ^a   Rezacova, Anna ^a   Placek, Lukas ^a   Tkadlecova, Marcela ^a   Havlicek, Jaroslav ^a   Dohnal, Jiri ^a,c   Jampílek, Josef ^a,c  

^a Zentiva Prague   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Co crystals; CP MAS NMR; D galactopyranosides; D glucopyranosides; FT NIR; FT Raman; Ibandronate; PAMPA

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DRUG DERIVATIVE; GALACTOSIDE; GLUCOSE; IBANDRONIC ACID; PHENYL D GALACTOPYRANOSIDE; PHENYL-D-GALACTOPYRANOSIDE;

ARTICLE; CHEMISTRY; CRYSTALLIZATION; INFRARED SPECTROSCOPY; METHODOLOGY; RAMAN SPECTROMETRY;

CRYSTALLIZATION; DIPHOSPHONATES; GALACTOSIDES; GLUCOSE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN;

EID: 78650630295     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15128973     Document Type: Article

References (25)

1. Ebetino, F.H.; Francis, M.D.; Rogers, M.J.; Russell, R.G.G. Mechanisms of action of etidronate and other bisphosphonates. Rev. Contemp. Pharmacother. 1998, 9, 233-243.
2. Sato, M.; Grasser, W.; Endo, N.; Akins, R.; Simmons, H.; Thompson, D.D.; Golub, E.; Rodan, G.A. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J. Clin. Invest. 1991, 88, 2095-2105.
3. Carano, A.; Teitelbaum, S.L.; Konsek, J.D.; Schlesinger, P.H.; Blair, H.C. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J. Clin. Invest. 1990, 85, 456-461.
4. Hughes, D.E.; Wright, K.R.; Uy, H.L.; Sasaki, A.; Yoneda, T.; Roodman, G.D.; Mundy, G.R.; Boyce, B.F. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res. 1995, 10, 1478-1487.
5. Selander, K.S.; Monkkonen, J.; Karhukorpi, E.K.; Harkonen, P.; Hannuniemi, R.; Vaananen, H.K. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol. Pharmacol. 1996, 50, 1127-1138.
6. Ito, M.; Amizuka, N.; Nakajima, T.; Ozawa, H. Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone 1999, 25, 447-452.
7. Reszka, A.A.; Halasy-Nagy, J.M.; Masarachia, P.J.; Rodan, G.A. Bisphosphonates act directly on the osteoclast to induce caspase cleavage of Mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase. J. Biol. Chem. 1999, 274, 34967-34973.
8. Rogers, M.J.; Xiong, X.; Brown, R.J.; Watts, D.J.; Russell, R.G.; Bayless, A.V.; Ebetino, F.H. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae. Mol. Pharmacol. 1995, 47, 398-402.
9. Rogers, M.J.; Gordon, S.; Benford, H.L.; Coxon, F.P.; Luckman, S.P.; Monkkonen, J.; Frith, J.C. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000, 88, 2961-2978.
10. van Beek, E.R.; Lowik, C.W.; Ebetino, F.H.; Papapoulos, S.E. Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: Structure-activity relationships. Bone 1998, 23, 437-442.
11. MedicineNet. http://www.medicinenet.com/ibandronate/article.htm/ (accessed on 16 November 2010).
12. Ezra, A.; Golomb, G. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Advan. Drug Delivery Rev. 2000, 42, 175-195.
13. Kerns, E.H.; Li, D. Drug-like Properties: Concept, Structure Design and Methods; Elsevier: San Diego, CA, USA, 2008.
14. Pharmaterials Ltd. http://www.pharmaterials.co.uk/co-crystals.html/ (accessed on 16 November 2010).
15. Tiekink, E.R.T., Vittal, J., Eds.; Frontiers in Crystal Engineering; Wiley-VCH: Wienheim, Germany, 2005.
16. Braga, D., Grepioni, F., Eds.; Making Crystals by Design: Methods, Techniques and Applications; Wiley-VCH: Wienheim, Germany, 2006.
17. Luypaert, J.; Massart, D.L.; Vander-Heyden Y. Near-infrared spectroscopy applications in pharmaceutical analysis. Talanta 2007, 72, 865-883.
18. Jampilek, J.; Oktabec, Z.; Pekarek, T.; Havlicek, J.; Dohnal, J.; Kral, V. Characterization of polymorphs and API-excipient co-crystals using vibration spectroscopy and solid-state NMR. In Proceedings of the 11th International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS® 11), Stamford, Connecticut, USA, 14-19 June 2009.
19. Jampilek, J.; Oktabec, Z.; Rezacova, A.; Placek, L.; Kos, J.; Havelkova, L.; Dohnal, J.; Kral, V. Preparation and properties of new co-crystals of ibandronate. In Proceedings of the 13th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-13), 1-30 November 2009. http://www.sciforum. net/presentation/201.
20. Jampilek, J.; Kos, J.; Oktabec, Z.; Mandelova, Z.; Pekarek, T.; Tkadlecova, M.; Havlicek, J.; Dohnal, J.; Kral V. Co-crystal screening study of risedronate and unsubstituted hexoses. In Proceedings of the 14th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-14), 1-30 November 2010. http://www.sciforum.net/presentation/421.
21. Eiermann, U.; Junghans, B.; Knipp, B.; Sattelkau, T.; Hoffmann-La Roche, Inc. Ibandronate polymorph B. WO/2006/081962, 10 August 2006.
22. Eiermann, U.; Junghans, B.; Knipp, B.; Sattelkau, T.; Hoffmann-La Roche, Inc. Ibandronate polymorph A. WO/2006/081963, 8 October 2006.
23. Lifshitz-Liron, R.; Bayer, T.; Aronhime, J.; TEVA Pharmaceutical. Solid and crystalline ibandronate sodium and processes for preparation thereof. WO/2006/024024, 3 February 2006.
24. Muddasani, P.R.; Vattikuti, U.; Nannapaneni, V.C. NATCO Pharma, Ltd. Novel polymorphic forms of ibandronate. WO/2007/074475, 7 May 2007.
25. Devarakonda, S.N.; Thaimattam, R.; Raghupati, B.; Asnani, M.; Vasamsetti, S.K. Rangineni, S.; Muppidi, V.K.; Dr. Reddy's Laboratories, Ltd. Ibandronate sodium polymorphs. U.S. Patent Application US2010/0125149 A1, 20 May 2010.